Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3196-3206

  AbouLaila, Mahmoud ^a   Munkhjargal, Tserendorj ^a   Sivakumar, Thillaiampalam ^a   Ueno, Akio ^a   Nakano, Yuki ^a   Yokoyama, Miki ^a   Yoshinari, Takeshi ^a   Nagano, Daisuke ^a   Katayama, Koji ^a   El Bahy, Nasr ^b   Yokoyama, Naoaki ^a   Igarashi, Ikuo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; DIMINAZENE ACETURATE; RIFAMPICIN; THIOSTREPTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; APICOPLAST; ARTICLE; BABESIA; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA EQUI; BABESIA MICROTI; BABESIOSIS; CONTROLLED STUDY; DNA REPLICATION; DNA TRANSCRIPTION; DRUG EFFECT; DRUG TARGETING; FEMALE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MICROBIAL GROWTH; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BABESIA; BABESIOSIS; BLOTTING, WESTERN; CLINDAMYCIN; FEMALE; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIFAMPIN; THIOSTREPTON;

EID: 84861168747     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05488-11     Document Type: Article

References (75)

1. AbouLaila M, Nakamura K, Govind Y, Yokoyama N, Igarashi I. 2010. Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites. Vet. Parasitol. 167:19-27.
2. AbouLaila M, Yokoyama N, Igarashi I. 2010. Inhibitory effects of (-)- epigallocatechin-3-gallate from green tea on the growth of Babesia parasites. Parasitology 137:785-791.
3. AbouLaila M, Sivakumar T, Yokoyama N, Igarashi I. 2010. Inhibitory effect of terpene nerolidol on the growth of Babesia parasites. Parasitol. Int. 59:278-282.
4. Akiba M, Saeki H, Ishii T, Yamamoto S, Ueda K. 1991. Immunological changes in Babesia rodhaini infected BALB/c mice after treated with antibabesial drug; diminazene diaceturate. J. Vet. Med. Sci. 53:371-377.
5. Aminake MN, et al. 2011. Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast. Antimicrob. Agents Chemother. 55:1338-1348.
6. Arai S, Tsuji M, Kim Nakade S-JT, Kanno Y, Ishihara C. 1998. Babesia canis infection in canine-red blood cell-substituted SCID mice. Int. J. Parasitol. 28:1429-1435. (Pubitemid 28386956)
7. Avarzed A, et al. 1997. Improved in vitro cultivation of Babesia caballi. J. Vet. Med. Sci. 59:479-481. (Pubitemid 127521884)
8. Barbrook AC, Howe CJ, Purton S. 2006. Why are plastid genomes retained in non-photosynthetic organisms? Trends Plant Sci. 11:101-108. (Pubitemid 43238421)
9. Barthel D, Schlitzer M, Pradel G. 2008. Telithromycin and quinupristindalfopristin induce delayed death in Plasmodium falciparum. Antimicrob. Agents Chemother. 52:774-777. (Pubitemid 351170864)
10. Berdy J. 1980. Handbook of antibiotic compounds, p 396. CRC Press Inc, Boca Raton, FL.
11. Bork S, et al. 2003. Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. Am. J. Trop. Med. Hyg. 68:334-340. (Pubitemid 38240524)
12. Bork S, et al. 2003. Clotrimazole, ketoconazole, and clodinafoppropargyl as potent growth inhibitors of equine Babesia parasites during in vitro cultures. J. Parasitol. 89:604-606. (Pubitemid 36828535)
13. Bork S, et al. 2003. Clotrimazole, ketoconazole, and clodinafoppropargyl inhibit the in vitro growth of Babesia bigemina and Babesia bovis (phylum Apicomplexa). Parasitology 127:311-315. (Pubitemid 37386413)
14. Bork S, et al. 2004. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob. Agents Chemother. 48:236-241. (Pubitemid 38040203)
15. Bork S, et al. 2004. Identification of Babesia bovis L-lactate dehydrogenase as a potential chemotherapeutic target against bovine babesiosis. Mol. Biochem. Parasitol. 136:165-172. (Pubitemid 38757985)
16. Bork S, Yokoyama N, Igarashi I. 2005. Recent advances in the chemotherapy of babesiosis by Asian scientists: toxoplasmosis and babesiosis in Asia. Asian Parasitol. 4:233-242.
17. Bork S, et al. 2005. Host serum modifies the drug susceptibility of Babesia bovis in vitro. J. Parasitol. 130:489-492. (Pubitemid 40685763)
18. Bork S, Das S, Okubo K, Yokoyama N, Igarashi I. 2006. Effects of protein kinase inhibitors on the in vitro growth of Babesia bovis. Parasitology 132:775-779.
19. Brasseur P, Lecoublet S, Kapel N, Vennec L, Ballet JJ. 1998. In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob. Agents Chemother. 42:818-820. (Pubitemid 28216360)
20. Brayton K, et al. 2007. Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathog. 3:1401-1413. (Pubitemid 350085605)
21. Brockelman CR, Tan-Ariya P. 1991. Development of an in vitro microtest to assess drug susceptibility of Babesia bovis and Babesia bigemina. J. Parasitol. 6:994-997.
22. Clough B, Strath M, Preiser P, Denny P, Wilson IR. 1997. Thiostrepton binds to malarial plastid rRNA. FEBS Lett. 406:123-125. (Pubitemid 27156972)
23. Cox FE, Young AS. 1969. Acquired immunity to Babesia microti and Babesia rodhaini in mice. Parasitology 59:257-268.
24. Divo A, Sartorelli A, Patton C, Bia F. 1988. Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 32:1182-1186.
25. Fichera ME, Roos DS. 1997. A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407-409. (Pubitemid 28027322)
26. Fichera ME, Bhopale MK, Roos DS. 1995. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob. Agents Chemother. 39:1530-1537.
27. Galley HF, Dhillon JK, Paterson RL, Webster NR. 2000. Effect of ciprofloxacin on the activation of the transcription factors nuclear factor κB, activator protein-1 and nuclear factor interleukin-6, and interleukin-6 and interleukin-8mRNAexpression in a human endothelial cell line. Clin. Sci. 99:405-410.
28. Goodman CD, Su V, McFadden GI. 2007. The effects of antibacterials on the malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 152:181-191.
29. Gozalbes R, et al. 2000. Anti-Toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques. Antimicrob. Agents Chemother. 44:2771-2776.
30. Gray JS, Pudney M. 1999. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus. J. Parasitol. 85:723-728. (Pubitemid 29383141)
31. Gürbay A. 2002. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum. Exp. Toxicol. 21:635-641. (Pubitemid 36124495)
32. He CY, et al. 2001. A plastid segregation defect in the protozoan parasite Toxoplasma gondii. EMBO J. 20:330-339. (Pubitemid 32126969)
33. Held J, Westerman R, Kremsner PG, Mordmüller B. 2010. In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon. Antimicrob. Agents Chemother. 54:540-542.
34. Hines SA, Palmer GH, Jasmer DP, McGuire TC, McElwain TF. 1992. Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family. Mol. Biochem. Parasitol. 55:85-94.
35. Homer MJ, Aguilar-Delfin I, Telford SR, Krause PJ, Persing DH. 2000. Babesiosis. Clin. Microbiol. Rev. 13:451-469. (Pubitemid 30452617)
36. Hotzel I, Suarez CE, McElwain TF, Palmer GH. 1997. Genetic variation in the dimorphic regions of RAP-1 genes and rap-1 loci of Babesia bigemina. Mol. Biochem. Parasitol. 90:479-489. (Pubitemid 28039803)
37. Hughes WT Oz HS. 1995. Successful prevention and treatment of babesiosis with atovaquone. J. Infect. Dis. 172:1042-1046.
38. Igarashi I, Njonge FK, Kaneko Y, Nakamura Y. 1998. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on the growth of parasites. Exp. Parasitol. 90:290-293. (Pubitemid 28525104)
39. Kjemtrup AM, Conrad PA. 2000. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol. 30:1323-1337.
40. Köhler S, et al. 1997. A plastid of probable green algal origin in apicomplexan parasites. Science 275:1485-1489. (Pubitemid 27111298)
41. Kuttler KL. 1988. Worldwide impact of babesiosis, p 2-22. In RisticM(ed), Babesiosis of domestic animals and man. CRC Press Inc, Boca Raton, FL.
42. Li J, Maga JA, Cermakian N, Cedergren R, Feagin JE. 2001. Identification and characterization of a Plasmodium falciparum RNA polymerase gene with similarity to mitochondrial RNA polymerases. Mol. Biochem. Parasitol. 113:261-269. (Pubitemid 32274299)
43. Lin Q, Katakura K, Suzuki M. 2002. Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline. FEBS Lett. 515: 71-74. (Pubitemid 34273900)
44. Marley SE, et al. 1997. Evaluation of selected antiprotozoal drugs in the Babesia microti hamster model. Antimicrob. Agents Chemother. 41:91-94. (Pubitemid 26428139)
45. Matsuu A, Yamasaki M, Xuan YX, Ikadai H, Yoshiaki H. 2008. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet. Parasitol. 157:1-8.
46. McConkey GA, Rogers MJ, McCutchan TF. 1997. Inhibition of Plasmodium falciparum protein synthesis: targeting the plastid-like organelle with thiostrepton. J. Biol. Chem. 272:2046-2049. (Pubitemid 27058476)
47. McFadden GI, Reith ME, Munholland J, Lang-Unnasch N. 1996. Plastid in human parasites. Nature 381:482. (Pubitemid 26170923)
48. Mehlhorn H, Schein E. 1998. Redescription of Babesia equi Laveran, 1901 as Theileria equi. Parasitol. Res. 84:467-475. (Pubitemid 28257176)
49. Nakamura K, Yokoyama N, Igarashi I. 2007. Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro. Parasitology 134:1347-1353. (Pubitemid 47236805)
50. Nicolaou KC, et al. 2005. Discovery of a biologically active thiostrepton fragment. J. Am. Chem. Soc. 127:15042-15044. (Pubitemid 41547368)
51. Nott SE, O'Sullivan WJ, Gero AM, Bagnara AS. 1990. Routine screening for potential babesicides using cultures of Babesia bovis. Int. J. Parasitol. 20:797-802. (Pubitemid 20334159)
52. Okubo K, et al. 2006. Calcium ions are involved in erythrocyte invasion by equine Babesia parasites. Parasitology 133:289-294. (Pubitemid 44214943)
53. Okubo K, Yokoyama N, Govind Y, Alhassan A, Igarashi I. 2007. Babesia bovis: effects of cysteine protease inhibitors on in vitro growth. Exp. Parasitol. 117:214-217. (Pubitemid 47331439)
54. Onodera Y, Tanaka M, Sato K. 2001. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47:447-450. (Pubitemid 32303411)
55. Pudney M, Gray JS. 1997. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. J. Parasitol. 83:307-310. (Pubitemid 27167225)
56. Pumell RE. 1981. Babesiosis in various hosts, p 25-63. In Ristic M, Kreier JP (ed), Babesiosis. Academic Press, New York, NY.
57. Ralph SA, D'Ombrain MC, McFadden GI. 2001. The apicoplast as an antimalarial drug target. Drug Resist. Updat. 4:145-151. (Pubitemid 33089452)
58. Riesbeck K, Sigvardsson M, Leanderson T, Forsgren A. 1994. Superinduction of cytokine gene transcription by ciprofloxacin. J. Immunol. 153:343-352. (Pubitemid 24186548)
59. Rodriguez RI, Trees AJ. 1996. In vitro responsiveness of B. bovis to imidocarb dipropionate and the selection of adapted lines. Vet. Parasitol. 62:35-41. (Pubitemid 26074484)
60. Rogers MJ, Burkham YV, McCutchan TF, Draper DE. 1997. Interaction of thiostrepton with an RNA fragment derived from the plastid-encoded ribosomal RNA of the malaria parasite. RNA 3:815-820. (Pubitemid 27332732)
61. Schoof S, et al. 2010. Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action. Angew. Chem. Int. Ed. Engl. 49:3317-3321.
62. Sriram D, et al. 2009. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species. Bioorg. Med. Chem. Lett. 19:1152-1154.
63. Strath M, Scott-Finnigan T, Gardner M, Williamson D, Wilson I. 1993. Antimalarial activity of rifampicin in vitro and in rodent models. Trans. R. Soc. Trop. Med. Hyg. 87:211-216.
64. Sullivan M, Li J, Kumar S, Rogers MJ, McCutchan TF. 2000. Effects of interruption of apicoplast function on malaria infection, development, and transmission. Mol. Biochem. Parasitol. 109:17-23. (Pubitemid 30621372)
65. Tarr SJ, Nisbet RE, Howe CJ. 2011. Transcript-level responses of Plasmodium falciparum to thiostrepton. Mol. Biochem. Parasitol. 179:37-41.
66. Telford SR, Spielman A. 1997. Babesiosis of humans, p 349-359. In Collier L, Balows A, Sussman M, Kreier JP (ed), Topley and Wilson's microbiology and microbial infections. Edward Arnold, London, United Kingdom.
67. Upcroft P. 1994. Multiple drug resistance in the pathogenic protozoa. Acta Trop. 56:195-212. (Pubitemid 24095231)
68. Vaishnava S, Striepen B. 2006. The cell biology of secondary endosymbiosis-how parasites build, divide and segregate the apicoplast. Mol. Microbiol. 61:1380-1387. (Pubitemid 44359369)
69. van Dooren GG, et al. 2005. Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. Mol. Microbiol. 57:405-419.
70. Vial HJ, Gorenflot A. 2006. Chemotherapy against babesiosis. Vet. Parasitol. 138:147-160. (Pubitemid 44275261)
71. Waller RF, McFadden GI. 2005. The apicoplast: a review of the derived plastid of apicomplexan parasites. Curr. Issues Mol. Biol. 7:57-79.
72. Weiss LM, et al. 1993. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J. Infect. Dis. 168:1289-1292. (Pubitemid 23317153)
73. Wilson RJ, Williamson DH. 1997. Extrachromosomal DNA in the apicomplexa. Microbiol. Mol. Biol. Rev. 61:1-16.
74. Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM. 1996. Atovaquone in the treatment of Babesia microti infections in hamsters. Am. J. Trop. Med. Hyg. 55:219-222. (Pubitemid 26299210)
75. Xie H-J, et al. 2003. Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome P450 genes by ciprofloxacin. Bone Marrow Transplant. 31:197-203. (Pubitemid 36305574)